Inventor · disambiguated record
Marc Jozef Lauwereys
Also filed as: LAUWEREYS MARC · LAUWEREYS MARC J · LAUWEREYS MARC JOZEF
15 granted patents·22 pending applications·150 citations·filing 1993–2024
93Inventor score
Top patents by PatentIndex Score
37 records- 0189US9265834B2Stable formulations of polypeptides and uses thereofABLYNX NV·Filed 2013·Granted Feb 23, 2016·8 cites·25 claims
- 0287US9371381B2Single domain antibodies directed against tumor necrosis factor-alpha and uses thereforABLYNX NV·Filed 2014·Granted Jun 21, 2016·5 cites·16 claims
- 0380US2025122547A1Method for the production of domain antibodiesABLYNX NV·Filed 2024·Application pending·0 cites
- 0479US10919954B2Antigen binding dimer-complexes, methods of making/avoiding and uses thereofABLYNX NV·Filed 2018·Granted Feb 16, 2021·1 cites·9 claims
- 0579US5866542ANematode-extracted anticoagulant proteinCORVAS INT INC·Filed 1995·Granted Feb 2, 1999·37 cites·50 claims
- 0678US10005830B2Antigen binding dimer-complexes, methods of making/avoiding and uses thereofBRIGE ANN·Filed 2010·Granted Jun 26, 2018·2 cites·10 claims
- 0778US5864009ANematode-extracted anticoagulant proteinCORVAS INT INC·Filed 1995·Granted Jan 26, 1999·25 cites·37 claims
- 0875US9464138B2Method for the production of domain antibodiesSCHOTTE PETER·Filed 2010·Granted Oct 11, 2016·3 cites·8 claims
- 0969US12492239B2Antigen binding dimer-complexes, methods of making/avoiding and uses thereofABLYNX NV·Filed 2021·Granted Dec 9, 2025·0 cites·19 claims
- 1068US9884117B2Stable formulations of polypeptides and uses thereofBRIGE ANN·Filed 2010·Granted Feb 6, 2018·2 cites·22 claims
- 1167US5866543ANematode-extracted anticoagulant proteinCORVAS INT INC·Filed 1995·Granted Feb 2, 1999·17 cites·22 claims
- 1264US2009022721A1Single domain antibodies directed against tumour necrosis factor-alpha and uses thereforABLYNX NV·Filed 2007·Application pending·0 cites
- 1364US2007237769A1Single domain antibodies directed against tumour necrosis factor-alpha and uses thereforABLYNX NV·Filed 2007·Application pending·0 cites
- 1463US2015064182A1Stabilized single domain antibodiesABLYNX NV·Filed 2014·Application pending·0 cites
- 1563US2007077249A1Single domain antibodies directed against tumour necrosis factor-alpha and uses thereforABLYNX NV·Filed 2006·Application pending·0 cites
- 1662US5872098ANematode-extracted anticoagulant proteinCORVAS INT INC·Filed 1995·Granted Feb 16, 1999·13 cites·42 claims
- 1762US2009238829A1Stabilized single domain antibodiesABLYNX NV·Filed 2007·Application pending·0 cites
- 1862US2017096481A1Single domain antibodies directed against tumor necrosis factor-alpha and uses thereforABLYNX NV·Filed 2016·Application pending·0 cites
- 1960US2012202977A1Single domain antibodies directed against tumor necrosis factor-alpha and uses thereforSILENCE KAREN·Filed 2012·Application pending·0 cites
- 2059US2011184150A1Single domain antibodies directed against tumor necrosis factor-alpha and uses thereforABLYNX NV·Filed 2011·Application pending·0 cites
- 2158US12116607B2Method for the production of domain antibodiesABLYNX NV·Filed 2016·Granted Oct 15, 2024·0 cites·17 claims
- 2258US2011027281A1Single domain antibodies directed against tumor necrosis factor-alpha and uses thereforABLYNX NV·Filed 2010·Application pending·0 cites
- 2357US2006034845A1Single domain antibodies directed against tumor necrosis factor alpha and uses thereforSILENCE KAREN·Filed 2003·Application pending·0 cites
- 2457US2017107302A1Stabilized single domain antibodiesABLYNX NV·Filed 2016·Application pending·0 cites
- 2557US2012251540A1Stabilized single domain antibodiesSILENCE KAREN·Filed 2012·Application pending·0 cites
- 2656US2011178277A1Stabilized single domain antibodiesABLYNX NV·Filed 2011·Application pending·0 cites
- 2753US5863894ANematode-extracted anticoagulant proteinCORVAS INT INC·Filed 1995·Granted Jan 26, 1999·15 cites·46 claims
- 2853US5585259AEcotin as a factor Xa, XIa, and XIIa inhibitorCORVAS INT INC·Filed 1993·Granted Dec 17, 1996·11 cites·1 claims
- 2952US5945275ANematode-extracted anticoagulant proteinCORVAS INT INC·Filed 1994·Granted Aug 31, 1999·11 cites·4 claims
- 3052US2011091462A1Novel antigen binding dimer-complexes, methods of making and uses thereofABLYNX NV·Filed 2009·Application pending·0 cites
- 3150US2016279242A1Stable formulations of polypeptides and uses thereofABLYNX NV·Filed 2016·Application pending·0 cites
- 3249US2011183861A1Methods to stabilize proteins and polypeptidesABLYNN N V·Filed 2009·Application pending·0 cites
- 3345US2007178082A1Stabilized single domain antibodiesABLYNX NV·Filed 2003·Application pending·0 cites
- 3441US2005214857A1Method for displaying loops from immunoglobulin domains in different contextsABLYNX NV·Filed 2002·Application pending·0 cites
- 3537US2008107601A1Nanobodies Tm Against Amyloid-Beta and Polypeptides Comprising the Same for the Treatment of Degenerative Neural Diseases Such as Alzheimer's DiseaseABLYNX NV·Filed 2005·Application pending·0 cites
- 3635US2013109842A1Amino acid sequences of nanobodies directed against p19 subunit of the heterodimeric cytokine il-23DE BRABANDERE VERONIQUE·Filed 2011·Application pending·0 cites
- 3734US2012264917A1Biparatopic protein constructs directed against il-23SAUNDERS MICHAEL JOHN SCOTT·Filed 2010·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →